Jordan Leitch
Jordan Leitch
The goal of this project is to examine the cardiac symptoms and physiologic changes after administration of a reduced dose of carbetocin in participants undergoing elective cesarian section. * Does reduced dose carbetocin (50mcg) have fewer cardiac side effects than usual dose carbetocin (100mcg) when comparing patient reported symptoms, ECG changes and troponin increases? * Is there a relationship between patient reported cardiac symptoms after carbetocin administration and subjective measures of cardiac ischemia (ECG changes and troponin increases? Researchers will compare 50mcg of carbetocin to the control group of 100mcg of carbetocin in patients undergoing elective cesarian section. Participants will: * Be given 50mcg or 100mcg of carbetocin during cesarian section * Asked to report cardiac symptoms * Be assessed for ECG changes and blood loss using standard of practice monitoring * Have a troponin I blood test completed after delivery
Cardiac Ischemia
Cesarian Section
Carbetocin
PHASE4
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 200 participants |
| Masking : | DOUBLE |
| Primary Purpose : | TREATMENT |
| Official Title : | Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section |
| Actual Study Start Date : | 2025-08-01 |
| Estimated Primary Completion Date : | 2026-08-01 |
| Estimated Study Completion Date : | 2027-09-01 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | FEMALE |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Kingston Health Sciences Centre
Kingston, Ontario, Canada, Kohl is a joyful